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NK cells present in the peripheral blood (PB) respond rapidly to pathogens or pathogen-
infected cells by various means including cytotoxicity and release of cytokines and
chemokines. In addition they modulate adaptive immunity via the interaction with dendritic
cells. Decidual NK cells (dNK) are poorly cytotoxic in healthy pregnancy, both in humans
and rodents, when compared to their PB counterparts. We will discuss recent findings that
may contribute to answer the following questions: (i) Do dNK possess functional killing
machinery in normal healthy pregnancy? (ii) If so, what are the regulatory mechanisms
that negatively control this effector function? (iii) Have dNK from early pregnant uterus the
intrinsic ability to kill pathogen-infected autologous maternal uterine cells and/or produce
soluble factors that stimulate the anti-pathogen adaptive immune response? (iv) Do dNK
undergo a receptor repertoire profile shift when they are in contact with pathogen-infected
uterine cells? (v) Which pathogen-mediated signal(s) and molecular interactions subvert
the inhibition of dNK cytolytic activity?
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INTRODUCTION
During the last decade, an increasing body of data based on genetic
and functional studies have provided compelling evidence that
during early healthy pregnancy, decidual NK (dNK) cells, the dom-
inant lymphocyte population accumulated in the decidua basalis
where the trophoblast cells infiltrate, exhibit unique functional
and phenotypic characteristics (1–5). More than 95% of dNK are
CD56bright CD16neg CD160neg (6). As opposed to dNK, the major
peripheral blood (PB)-NK cell subset is CD56dim CD16+ CD160+,
a specific phenotype associated with cytotoxic activity (6, 7). dNK
cells express the two-domain killer immunoglobulin-like receptor
(KIR) at higher frequency than PB-NK (8). This KIR2D repertoire
is biased toward recognizing HLA-C, the dominant KIR ligand
expressed by fetal extravillous trophoblast (8). PB-NK mostly
contribute to the innate immunity against pathogen-infected or
tumor cells by their cytolytic activity as well as release of pro-
inflammatory cytokines and chemokines (9). In healthy pregnant
uterus, dNK are poorly cytotoxic and have specialized pregnancy-
specific functions, including a capacity to produce angiogenic
molecules and to control trophoblast invasion (10–15). Until very
recently (16), little information existed on the dNK capability of
limiting local decidual pathogen infection.
DECIDUAL NK CELLS PRODUCE SOLUBLE FACTORS THAT
INFLUENCE PLACENTAL DEVELOPMENT IN NORMAL
PREGNANCY
Human dNK, in contrast with PB-NK, control two crucial func-
tions in early healthy pregnancy. Firstly, dNK promote vascular
growth in the decidua through the production of vascular
endothelial growth factor (VEGF) and placental growth factor
(PlGF) (9, 13, 17–19) as well as of angiopoietin 1, angiopoietin
2, and TGF-β1 (15, 20). The release of these proangiogenic fac-
tors by dNK cells depends on the engagement of both NKp30 and
NKp44 activating receptors by their specific ligands present on
stromal decidual cells and extravillous trophoblast (17). Engage-
ment of another NK cell receptor, KIR2DL4, by soluble HLA-G
specific ligand was shown to induce the production of proangio-
genic cytokines (21). Since KIR2DL4 is expressed by dNK either
at the cell surface (22) or intracellularly (21), and soluble HLA-
G is secreted by trophoblast (23), this receptor-ligand couple is
likely to contribute to the remodeling of the maternal vasculature
in early pregnancy. The same authors have demonstrated that the
KIR2DL4-induced senescence secretome of PB-NK can promote
vascular remodeling and angiogenesis (24). Analysis of the dNK
cell transcriptome revealed a strong similar senescence signature
(24). Secondly, dNK release interleukin-8 (IL-8) and interferon-
inducible protein-10 (IP-10) chemokines that favor the migration
of the extravillous cytotrophoblast into the decidua basalis by
interacting with the CXCR3 and CXCR1 receptors expressed by the
trophoblast cells (17). Migration of extravillous trophoblast cells
results in the invasion of spiral arteries thus contributing to the
uterine vascular remodeling crucial for the placental development
and outcome of pregnancy (25). Such production of chemoattrac-
tants by dNK is due to the engagement of NKp30 and NKp44 by
their specific ligands expressed by trophoblast and stromal decid-
ual cells (17). Similar interactions between dNK and trophoblast
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were observed in pregnant mouse, leading to mesometrial spi-
ral artery remodeling (26–28). Activation of the KIR2DS1 dNK
receptor by HLA-C2 was shown to produce the GM-CSF solu-
ble factor, which enhanced migration of trophoblast (29). Other
reports from our laboratory indicated that a specific engagement
of NKp30 activating receptor on dNK induced the release of several
soluble inflammatory and growth factors, including IFN-γ, TNF-
α, MIP1-α, MIP1-β, and GM-CSF (22, 30). During viral infection,
these molecules are important to recruit and activate eosinophils,
macrophages, and dendritic cells (31).
DO DECIDUAL NK CELLS POSSESS FUNCTIONAL LYTIC
MACHINERY IN NORMAL HEALTHY PREGNANCY?
Human PB-NK are important innate immune effector cells that
rapidly respond to and destroy malignant or virally infected cells
(32). PB-NK kill infected cells via the polarized release of cytotoxic
granules and the formation of immune synapse between the target
cell and the PB-NK. The balance between activating and inhibitory
NK cell receptor engagement upon recognition of specific cellular
ligands determines the degree of NK cell activation or inactivation.
In contrast to PB-NK, it has been demonstrated that both human
dNK and mouse uterine NK cells displayed a poor ability to kill
various classical NK cell targets (12, 28, 33). dNK cells fail to polar-
ize their microtubules organizing centers and perforin-containing
granules to the synapse when they are in contact with HLA class
I negative target cells (33). Although dNK cells fail to fully exert
their lytic properties in normal pregnancy, they have lytic granules
containing perforin, granzyme, and granulysin (34), indicating
that they are potentially capable of cytolytic activity. Using redi-
rected cell lysis assay, it has been shown that specific monoclonal
antibody engagement of NKp46 activating receptor expressed on
freshly isolated dNK induced intracellular calcium mobilization,
granule exocytosis, and efficient P815 target cell lysis (22). It is of
note that uterine NK cells in pregnant mice express the natural
cytotoxicity receptor 1 (NCR1), an ortholog of human NKp46
also present in other species (35). This evolutionary conservation
suggests that NKp46 could be involved in pathogen recognition
(36). Experiments performed in mice homozygous for NCR1 loss
revealed the role of NCR1 in the clearance of influenza virus
infection (37). It has been demonstrated that granulysin release
from mouse uterine NK cells in spontaneous abortion induced
apoptosis of extravillous cytotrophoblast (28). All of these data
strongly suggested that both human and mouse NK cells have the
capability to exert a cytotoxic effector function in the pregnant
uterus.
WHAT ARE THE REGULATORY MECHANISMS THAT
NEGATIVELY CONTROL THE CYTOTOXIC FUNCTION OF
DECIDUAL NK CELLS IN NORMAL PREGNANCY?
The importance of the balance between activating and inhibitory
signals mediated by the specific engagement of activating and
inhibitory NK cell receptors has been underlined by a num-
ber of reports (38). In addition to the inhibitory KIRs, three
other dNK receptors play an inhibitory function, namely 2B4,
CD94/NKG2A, and LILRB1/ILT2. Whereas 2B4 was shown to
be expressed on all dNK (22, 39), both CD94/NKG2A and
LILRB1/ILT2 are only present on a subset of dNK (8, 12, 22,
33). Specific interaction between inhibitory dNK receptors and
either MHC class Ia (HLA-C) or MHC class Ib molecules (HLA-
E, HLA-G) in human play an important role (40). We found
that the co-engagement of CD94/NKG2A inhibitory receptor trig-
gered a drastic inhibition of the cytolytic function of freshly
isolated dNK from early decidua basalis (22). These results sug-
gest that in situ the CD94/NKG2A receptor interaction with
its HLA-E specific ligand expressed by trophoblast and other
decidual cells is a dominant negative regulatory mechanism that
likely prevents unwanted cytotoxicity toward non-infected fetal-
derived trophoblast cells. Another inhibitory mechanism depends
on the engagement of the LILRB1/ILT2 dNK receptor by HLA-G
which blocks dNK cytotoxicity (41, 42). It was also demonstrated
that VEGF-C released by dNK in early pregnancy induced up-
regulation of TAP-1 in extravillous cytotrophoblast protecting
them from cytolysis (13). Expression of the inhibitory form of
2B4 receptor on dNK also contributes to negatively regulate lytic
function of dNK (39). Several regulatory mechanisms thus con-
tribute to block the functional cytolytic machinery of dNK in
normal pregnancy.
HAVE DECIDUAL NK CELLS FROM EARLY PREGNANT UTERUS
THE INTRINSIC ABILITY TO KILL PATHOGEN-INFECTED
AUTOLOGOUS DECIDUAL CELLS AND PRODUCE SOLUBLE
FACTORS THAT STIMULATE THE ANTI-PATHOGEN ADAPTIVE
IMMUNE RESPONSE?
A variety of pathogens, including human cytomegalovirus
(hCMV) (10), human immunodeficiency virus 1 (HIV-1) (43),
hepatitis C virus (44), toxoplasma (45), Plasmodium falciparum
(46), bacteria in chorioamnionitis (10, 47) can infect the decidua
basalis and potentially spread to the fetus through anchoring villi
which are in contact with maternal blood of the intervillous space
(23, 48). We will mainly focus on data dealing with hCMV which
frequently infects decidua and has been detected in decidual stro-
mal, macrophages, and endothelial cells (49). Areas of decidual
hCMV infection were shown not to contain T cell accumula-
tion, suggesting that, in addition to the humoral immunity (10),
dNK could be another effector cell of the local anti-viral innate
immunity preventing virus spread to the fetus. This hypothesis
was recently validated by the observation that on biopsies of pla-
cental samples from hCMV termination, dNK have been identified
in the vicinity of hCMV positive cells (16).
DECIDUAL NK CELLS FULLY EXERT THEIR KILLING EFFECTOR FUNCTION
WHEN IN CONTACT WITH hCMV-INFECTED AUTOLOGOUS DECIDUAL
FIBROBLASTS
A recent report from our lab has demonstrated that dNK play a
role in the control of decidual cell hCMV infection (16). When
exposed to hCMV-infected decidual autologous fibroblasts, a cell
type abundantly present in decidual tissue, dNK acquires major
functional and phenotypic changes (16). As opposed to dNK cells
in contact to uninfected autologous decidual fibroblast, dNK cells
engage immune synapse with hCMV-infected autologous stromal
cells, polarize their lytic machinery toward infected target cells and
efficiently kill them (16). Thus, the co-culture of dNK from early
gestation with infected autologous decidual cells clearly enhances
their cytotoxic ability.
Frontiers in Immunology | NK Cell Biology November 2013 | Volume 4 | Article 404 | 2
Le Bouteiller Decidual NK and pathogen infection
DECIDUAL NK CELLS MODULATE THEIR CYTOKINE AND CHEMOKINES
PRODUCTION WHEN IN CONTACT WITH hCMV- OR HIV-1-INFECTED
DECIDUAL FIBROBLASTS
Co-culture of dNK from early gestation with hCMV-infected
autologous fibroblast induced a significant increased secretion of
VEGF-A, sICAM,CXCL-1, IL-6,Granzyme-B,and MCP-1 by com-
parison with dNK in contact with uninfected similar target cells
(16). IL-6 is a multifunctional cytokine that includes directing
T cells differentiation in adaptive immunity (50). Although the
first trimester pregnancy decidua is permissive to HIV-1 infection
in vitro, the frequency of early in utero mother-to-child trans-
mission of HIV-1 is low, suggesting efficient inhibitory regulatory
mechanisms (51). dNK secrete cytokines and chemokines known
to inhibit HIV-1 infection like CCL-3 and CCL4 or CXCL-12 (51).
The killing of HIV-1-infected decidual cells by dNK could be
mediated by specific engagement of NK cell receptors but also
by induction of apoptosis mediated by the Fas/FasL pathway (51)
as dNK were shown to produce FasL (52).
DO DECIDUAL NK CELLS UNDERGO A RECEPTOR
REPERTOIRE PROFILE SHIFT WHEN THEY ARE IN CONTACT
WITH PATHOGEN-INFECTED UTERINE CELLS?
hCMV infection modulates dNK cell receptor repertoire abil-
ity to kill virally infected decidual cells. Such a killing requires
interaction between dNK cell activating receptors and specific
ligands expressed at the cell surface of autologous decidual infected
cells. Co-culture of dNK for 48 h with hCMV-infected decidual
fibroblasts and without addition of IL-2 or IL-15, significantly
increased the number of CD56dim dNK, associated with appear-
ance of CD16 (16). This dNK phenotype is consistent with acqui-
sition of a cytotoxic profile (16). A recent study similarly reported
a significant increase of the CD56dim CD16+ dNK subpopula-
tion as early as 12 h after in vitro infection with Toxoplasma when
compared to uninfected dNK (53). Furthermore, hCMV infec-
tion induced increased levels of expression of NKp44 and NKG2C
receptors (16). Another study found that hCMV infection pro-
moted a persistent expansion of PB-NK cells that express the
CD94/NKG2C activating receptor (54). It is of note that the CD94-
NKG2 system is highly conserved in both rodents and primates
(55), highlighting the critical activating function of this recep-
tor/ligand couple. No change of NKp30 expression was noticed on
dNK cells after contact with hCMV-infected fibroblast (16). When
comparison was made between dNK and PB-NK, no significant
change was observed in the expression of PB-NK cell repertoire
after contact with hCMV-infected cells (16).
Disappearance of the NKp46high dNK subset and decrease
of KIR2DL1, KIR2DL4, and LILRB1/ILT2 expression were also
observed on dNK in contact with hCMV-infected decidual fibrob-
lasts (16). Thus, exposure to hCMV-infected cells modulates dNK
receptor repertoire. An up-regulation of the NKG2D activating
Table 1 | Decidual NK receptor-ligands interactions, signals and cytotoxic effector functions.






Uninfected decidual fibroblasts CD56bright ∼95% CD94/NKG2Ab HLA-E Negative NO
CD56dim ≤5% KIR2DL1b HLA-C Negative
ILT2b HLA-Gd Negative
2B4a Negative
NKG2Dc NKG2D-L: high level Negative
CD94/NKG2C NKG2C-L ?
KIR2DL4b HLA-Gd ?
NKp30a NKp30-L: low level No signal
NKp44a NKp44-L: high level No signal
NKp46c NKp46-L: low level No signal
CD16neg
hCMV-infected decidual fibroblasts CD56bright ∼48% CD94/NKG2A: down HLA-E: down ? YES
CD56dim ∼40% KIR2DL1: down HLA-C ?
ILT2: down HLA-Gd ?
NKG2Dc NKG2D-L: down Positive
CD94/NKG2C: up HLA-E: down Positive
KIR2DL4: down HLA-Gd ?
NKp30a NKp30-L: up No signal
NKp46: down NKp46-L No signal




c100% positive cells (flow cytometry).
dHLA-G is expressed on extravillous cytotrophoblast present among decidual adherent cells.
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receptor expression was reported in Toxoplasma-infected dNK
which correlated with enhanced cytolytic activity against human
extravillous cytotrophoblast target cells (53). Based on these data,
infection of decidua by other pathogens is likely to trigger a change
in the repertoire profile of dNK receptors.
WHICH PATHOGEN-MEDIATED SIGNAL(S) AND MOLECULAR
INTERACTIONS SUBVERT THE INHIBITION OF DECIDUAL NK
CELL CYTOLYTIC ACTIVITY?
Using Fc-chimeric proteins, we found that hCMV infection of
decidual fibroblast modulated the expression of several NKR lig-
ands: NKp30L and NKG2DL were significantly increased whereas
NKp44L and NKp46L decreased (16). Blocking the engagement
of NKp44 with its specific ligand resulted in an increase killing
of infected autologous fibroblast by dNK cells, suggesting the
presence of an inhibitory form of NKp44. In contrast, blocking
NKG2D ligation induced a decrease of dNK cytotoxicity. These
observations suggested a crucial role of NKG2D-mediated cyto-
toxic function of dNK against hCMV-infected fibroblasts. Infec-
tion of decidual fibroblast resulted in a diminishment of HLA-E
expression on their cell surface. Blockade of HLA-E ligation with
its specific dNK cell receptor induced a decrease of dNK killing,
suggesting that HLA-E on hCMV-infected autologous fibroblasts
did bind the CD94/NKG2C activating receptor. In contrast, nei-
ther NKp46 nor NKp30 seemed to be implicated in dNK cell lytic
response. dNK cell subset that expresses the LILRB1/ILT2 receptor
could be involved in the control of HIV-1 infection as it has been
demonstrated in the PB-NK counterpart (56).
All of these data, including those dealing with hCMV infection
and summarized in Table 1, showed that pathogen-mediated sig-
nals (i.e., modulation of expression of dNK receptor-ligands sys-
tems) and molecular interactions (engagement of dNK receptors
with specific pathogen-mediated ligands) contribute to subvert
the inhibition of dNK cell cytotoxic activity observed in normal
pregnancy.
CONCLUSION
Instead of being detrimental, dNK cells have positive effects in
healthy human pregnancy as they promote placental development
through the crucial release of angiogenic factors and attraction
of extravillous trophoblast. After contact with hCMV-infected
autologous decidual fibroblasts, dNK acquire cytotoxic capac-
ity by subverting their killing inhibitory regulatory mechanisms
occurring in normal pregnancy. Effector functions of dNK in
pathogen-infected pregnancy require engagement of shifted reper-
toire of activating and/or inhibiting dNK cell receptors by specific
ligands up- or down-regulated in pathogen-infected decidual cells,
including HLA-E and NKG2DL. These results, if confirmed by fur-
ther studies dealing with different viruses or pathogens, strongly
suggest that, in situ, dNK are likely to contribute to local pathogen
innate immune control and clearance during the initial phase of
decidua infection.
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